Segment Information (Tables)

12 Months Ended

Dec. 31, 2023

Segment Reporting [Abstract]

Schedule of Segment Information

The following table summarizes segment information for the years ended December 31, 2023, 2022 and 2021 (in thousands):

	2023		2022		2021
Net revenue:
Clinical Services	$	495,636	$	418,754	$	404,172
Advanced Diagnostics	96,007		90,974		80,157
Total net revenue	591,643		509,728		484,329
Cost of revenue:
Clinical Services(1)	287,059		261,742		244,360
Advanced Diagnostics(2)	59,980		60,090		52,909
Total cost of revenue	347,039		321,832		297,269
Gross profit:
Clinical Services	208,577		157,012		159,812
Advanced Diagnostics	36,027		30,884		27,248
Total gross profit	244,604		187,896		187,060

(1) Clinical Services cost of revenue for the years ended December 31, 2023 and December 31, 2022 include $17.3 million and $17.1 million, respectively, of amortization of acquired intangible assets.

(2) Advanced Diagnostics cost of revenue for both the years ended December 31, 2023 and December 31, 2022 include $2.4 million of amortization of acquired intangible assets.